Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.
The global Next Generation Sequencing Technology market is projected to reach US$ 12360 million in 2029, increasing from US$ 4486 million in 2022, with the CAGR of 15.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next Generation Sequencing Technology market research.
The Next Generation Sequencing (NGS) Technology market is driven by the increasing demand for personalized medicine and advancements in genomic research. NGS technology enables rapid and high-throughput DNA and RNA sequencing, offering insights into genetic variations and molecular profiles for various applications in healthcare and life sciences. The rise in genetic diseases and cancer cases contributes to market growth as researchers and clinicians seek comprehensive genetic information for diagnosis, treatment, and drug development. Moreover, technological innovations in sequencing platforms and data analysis align with improved accuracy, speed, and cost-effectiveness of sequencing processes. However, the market also faces challenges, including managing and interpreting large volumes of genomic data and addressing ethical and privacy concerns related to genetic information. Additionally, ensuring standardization and quality control in NGS workflows and navigating regulatory requirements can pose obstacles for stakeholders. To succeed, companies must focus on data analytics solutions, collaborations in multi-omics research, and addressing the challenges to meet the increasing demand for NGS technology that drives advancements in personalized medicine and genomics research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Next Generation Sequencing Technology market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next Generation Sequencing Technology report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Next Generation Sequencing Technology 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 麻豆原创 by Application
1.3.1 Global Next Generation Sequencing Technology 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing Technology 麻豆原创 Perspective (2018-2029)
2.2 Next Generation Sequencing Technology Growth Trends by Region
2.2.1 Global Next Generation Sequencing Technology 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Next Generation Sequencing Technology Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Next Generation Sequencing Technology Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Next Generation Sequencing Technology 麻豆原创 Dynamics
2.3.1 Next Generation Sequencing Technology Industry Trends
2.3.2 Next Generation Sequencing Technology 麻豆原创 Drivers
2.3.3 Next Generation Sequencing Technology 麻豆原创 Challenges
2.3.4 Next Generation Sequencing Technology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing Technology Players by Revenue
3.1.1 Global Top Next Generation Sequencing Technology Players by Revenue (2018-2023)
3.1.2 Global Next Generation Sequencing Technology Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Next Generation Sequencing Technology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing Technology Revenue
3.4 Global Next Generation Sequencing Technology 麻豆原创 Concentration Ratio
3.4.1 Global Next Generation Sequencing Technology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing Technology Revenue in 2022
3.5 Next Generation Sequencing Technology Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing Technology Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing Technology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing Technology Breakdown Data by Type
4.1 Global Next Generation Sequencing Technology Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Next Generation Sequencing Technology Forecasted 麻豆原创 Size by Type (2024-2029)
5 Next Generation Sequencing Technology Breakdown Data by Application
5.1 Global Next Generation Sequencing Technology Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Next Generation Sequencing Technology Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Next Generation Sequencing Technology 麻豆原创 Size (2018-2029)
6.2 North America Next Generation Sequencing Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Next Generation Sequencing Technology 麻豆原创 Size by Country (2018-2023)
6.4 North America Next Generation Sequencing Technology 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing Technology 麻豆原创 Size (2018-2029)
7.2 Europe Next Generation Sequencing Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Next Generation Sequencing Technology 麻豆原创 Size by Country (2018-2023)
7.4 Europe Next Generation Sequencing Technology 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing Technology 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Next Generation Sequencing Technology 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Next Generation Sequencing Technology 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Next Generation Sequencing Technology 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing Technology 麻豆原创 Size (2018-2029)
9.2 Latin America Next Generation Sequencing Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Next Generation Sequencing Technology 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Next Generation Sequencing Technology 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing Technology 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Next Generation Sequencing Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Next Generation Sequencing Technology 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Next Generation Sequencing Technology 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Detail
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Next Generation Sequencing Technology Introduction
11.1.4 Eurofins Scientific Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Detail
11.2.2 Natera Business Overview
11.2.3 Natera Next Generation Sequencing Technology Introduction
11.2.4 Natera Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Detail
11.3.2 BGI Business Overview
11.3.3 BGI Next Generation Sequencing Technology Introduction
11.3.4 BGI Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Next Generation Sequencing Technology Introduction
11.4.4 Illumina Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Next Generation Sequencing Technology Introduction
11.5.4 Roche Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Next Generation Sequencing Technology Introduction
11.6.4 LabCorp Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Next Generation Sequencing Technology Introduction
11.7.4 Berry Genomics Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Detail
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences Next Generation Sequencing Technology Introduction
11.8.4 Brooks Life Sciences Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Detail
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Next Generation Sequencing Technology Introduction
11.9.4 Macrogen Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.9.5 Macrogen Recent Development
11.10 Personalis
11.10.1 Personalis Company Detail
11.10.2 Personalis Business Overview
11.10.3 Personalis Next Generation Sequencing Technology Introduction
11.10.4 Personalis Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.10.5 Personalis Recent Development
11.11 Novogene
11.11.1 Novogene Company Detail
11.11.2 Novogene Business Overview
11.11.3 Novogene Next Generation Sequencing Technology Introduction
11.11.4 Novogene Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.11.5 Novogene Recent Development
11.12 Genotypic Technology
11.12.1 Genotypic Technology Company Detail
11.12.2 Genotypic Technology Business Overview
11.12.3 Genotypic Technology Next Generation Sequencing Technology Introduction
11.12.4 Genotypic Technology Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.12.5 Genotypic Technology Recent Development
11.13 Dna Link
11.13.1 Dna Link Company Detail
11.13.2 Dna Link Business Overview
11.13.3 Dna Link Next Generation Sequencing Technology Introduction
11.13.4 Dna Link Revenue in Next Generation Sequencing Technology Business (2018-2023)
11.13.5 Dna Link Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
听
听
*If Applicable.
